Issue 2/2019
Content (8 Articles)
Alzheimer’s Disease Clinical Trials: Moving Toward Successful Prevention
Michael S. Rafii, Paul S. Aisen
Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder
Paola Maccioni, Giancarlo Colombo
Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management
Thomas Rego, Sarah Farrand, Anita M. Y. Goh, Dhamidhu Eratne, Wendy Kelso, Simone Mangelsdorf, Dennis Velakoulis, Mark Walterfang
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
Holly Green, Panagiota Tsitsi, Ioanna Markaki, Dag Aarsland, Per Svenningsson
The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin
John M. Wild, Saleh Aljarudi, Philip E. M. Smith, Carlo Knupp
Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study
Mei-Tzu Wang, Hsin-Li Liang, Cheng Chung Hung, Pei-Ling Tang, Kun-Chang Lin, Cheng-Hung Chiang, Feng-You Kuo, Jin-Shiou Yang, Chun-Peng Liu, Guang-Yuan Mar, Wei-Chun Huang
Intravenous Corticosteroids as an Adjunctive Treatment for Refractory and Super-Refractory Status Epilepticus: An Observational Cohort Study
Vasiliki Pantazou, Jan Novy, Andrea O. Rossetti